Supportive Care in Cancer

, Volume 6, Issue 3, pp 244–247

Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics

  • G. R. Morrow
  • Joseph A. Roscoe
  • Jeffrey J. Kirshner
  • Harry E. Hynes
  • Richard J. Rosenbluth
REVIEW ARTICLE

DOI: 10.1007/s005200050161

Cite this article as:
Morrow, G., Roscoe, J., Kirshner, J. et al. Support Care Cancer (1998) 6: 244. doi:10.1007/s005200050161

Abstract

Cancer chemotherapy is known to lead to nausea and vomiting in a large proportion of cases. If emesis is severe it can lead in its turn to anticipatory nausea and vomiting (ANV), which cannot be controlled by antiemetic medication. The etiology of ANV and various methods that have been used to counteract the condition are discussed.

Key words CancerChemotherapyAntiemeticsAnticipatory nausea and vomitingBehavioral therapyAnxiety

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • G. R. Morrow
    • 1
  • Joseph A. Roscoe
    • 1
  • Jeffrey J. Kirshner
    • 2
  • Harry E. Hynes
    • 3
  • Richard J. Rosenbluth
    • 4
  1. 1.University of Rochester Cancer Center, Rochester, N.Y., USAUS
  2. 2.Syracuse Hemotology-Oncology CCOP, Syracuse, N.Y., USAUS
  3. 3.Wichita CCOP, Wichita, Ka., USAUS
  4. 4.Northern New Jersey CCOP, Hackensack, N.J., USAUS